Skip to content

A Preliminary Study on the Effects of Dietary Management Using Digital Technology on Body Weight and Continuous Glucose Monitoring Parameters

A Preliminary Study on the Effects of Dietary Management Using Digital Technology on Body Weight and Continuous Glucose Monitoring Parameters - Digital Dietary Management Pilot Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000061046
Enrollment
10
Registered
2026-03-25
Start date
2026-03-25
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

During Week 1, participants will undergo an observation period without the use of digital dietary management tools. During Week 2, they will engage in a dietary management period using a generative AI

Sponsors

Kanazawa University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Adults aged 20 to 75 years 2) Able to perform basic smartphone or PC operations 3) Able to understand the study and provide written informed consent 4) Able to complete the 2-week observation period 5) Not meeting any exclusion criteria

Exclusion criteria

Exclusion criteria: 1) Women who are pregnant or breastfeeding 2) Patients with diabetes receiving insulin therapy 3) Individuals who have undergone surgery requiring general anesthesia within the past 3 months 4) Individuals currently under treatment for severe psychiatric disorders 5) Individuals judged to have insufficient cognitive ability to understand the study and provide appropriate informed consent 6) Individuals for whom placement of the FreeStyle Libre 2 sensor is difficult (e.g., severe skin disease, wounds or infection at the application site, history of adhesive allergy, or physical difficulty in sensor placement) 7) Individuals currently receiving treatment for eating disorders 8) Individuals on dialysis or with urinary protein of 1+ or greater 9) Individuals with severe hepatic dysfunction (Child-Pugh class C) 10) Individuals who have participated in another clinical study or trial within the past 1 month 11) Individuals judged by the principal investigator to be inappropriate for participation

Design outcomes

Primary

MeasureTime frame
1) Body Weight Change 2) Continuous Glucose Monitoring Parameters

Countries

Japan

Contacts

Public ContactMitsuhiro Kometani

Kanazawa University Department of Health Promotion and Medicine of the Future

mkome@med.kanazawa-u.ac.jp076-265-2778

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026